Viberzi is indicated in the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults. The drug has been shown to relieve the two main symptoms of IBS-D by making stools less loose and watery and reducing bowel contraction. Eluxadoline mixed mu- and kappa-opioid receptor agonist and delta-opioid receptor antagonist provides continued symptom relief in IBS-D
Viberzi is indicated in the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults. The drug has been shown to relieve the two main symptoms of IBS-D by making stools less loose and watery and reducing bowel contraction. Eluxadoline mixed mu- and kappa-opioid receptor agonist and delta-opioid receptor antagonist provides continued symptom relief in IBS-D